$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 10 11 12 13 14 15 16 17 18 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 0.78 | 12,552 | 9,803 | 39,152 | 26.6 K to 39.2 K (+47.19 %) |
| Feb 28 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.49 | 3,846 | 167,251 | 1,833,136 | 1.8 M to 1.8 M (-0.21 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 38.80 | 2,500 | 97,002 | 71,969 | 74.5 K to 72 K (-3.36 %) |
| Feb 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 37.21 | 10,000 | 372,100 | 1,014,785 | 1 M to 1 M (-0.98 %) |
| Feb 21 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | M | 0.78 | 12,551 | 9,802 | 12,552 | |
| Feb 21 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 39.65 | 12,551 | 497,647 | 26,600 | 39.2 K to 26.6 K (-32.06 %) |
| Feb 21 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 0.78 | 12,551 | 9,802 | 39,151 | 26.6 K to 39.2 K (+47.18 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | M | 0.78 | 12,551 | 9,802 | 25,103 | |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 38.25 | 12,551 | 480,076 | 26,600 | 39.2 K to 26.6 K (-32.06 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 0.78 | 12,551 | 9,802 | 39,151 | 26.6 K to 39.2 K (+47.18 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 1,500 | 8,595 | 291 | |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 37.70 | 1,500 | 56,550 | 27,048 | 28.5 K to 27 K (-5.25 %) |
| Feb 17 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 1,500 | 8,595 | 28,548 | 27 K to 28.5 K (+5.55 %) |
| Feb 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 37.08 | 3,846 | 142,614 | 1,836,982 | 1.8 M to 1.8 M (-0.21 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Grant | A | 19.46 | 629 | 12,238 | 15,493 | 14.9 K to 15.5 K (+4.23 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Grant | A | 39.92 | 264 | 10,539 | 14,864 | 14.6 K to 14.9 K (+1.81 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Grant | A | 19.46 | 736 | 14,320 | 16,525 | 15.8 K to 16.5 K (+4.66 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Grant | A | 39.92 | 264 | 10,539 | 15,789 | 15.5 K to 15.8 K (+1.70 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 19.46 | 167 | 3,249 | 110,941 | 110.8 K to 110.9 K (+0.15 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 39.92 | 264 | 10,539 | 110,774 | 110.5 K to 110.8 K (+0.24 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Grant | A | 19.46 | 657 | 12,783 | 130,627 | 130 K to 130.6 K (+0.51 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Grant | A | 39.92 | 264 | 10,539 | 129,970 | 129.7 K to 130 K (+0.20 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Grant | A | 19.46 | 286 | 5,565 | 27,048 | 26.8 K to 27 K (+1.07 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Grant | A | 39.92 | 264 | 10,539 | 26,762 | 26.5 K to 26.8 K (+1.00 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 19.46 | 148 | 2,880 | 1,024,785 | 1 M to 1 M (+0.01 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 39.92 | 57 | 2,275 | 1,024,637 | 1 M to 1 M (+0.01 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Grant | A | 19.46 | 370 | 7,199 | 21,793 | 21.4 K to 21.8 K (+1.73 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Grant | A | 39.92 | 264 | 10,539 | 21,423 | 21.2 K to 21.4 K (+1.25 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Grant | A | 19.46 | 606 | 11,791 | 12,236 | 11.6 K to 12.2 K (+5.21 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Grant | A | 39.92 | 264 | 10,539 | 11,630 | 11.4 K to 11.6 K (+2.32 %) |
| Feb 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 38.00 | 2,000 | 76,000 | 25,268 | 27.3 K to 25.3 K (-7.33 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Grant | A | 19.46 | 1,092 | 21,246 | 28,600 | 27.5 K to 28.6 K (+3.97 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Grant | A | 39.92 | 240 | 9,581 | 27,508 | 27.3 K to 27.5 K (+0.88 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Grant | A | 19.46 | 543 | 10,565 | 9,993 | 9.5 K to 10 K (+5.75 %) |
| Feb 13 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Grant | A | 39.92 | 264 | 10,539 | 9,450 | 9.2 K to 9.5 K (+2.87 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Sell | S | 42.00 | 1,000 | 42,000 | 0 | 1,000 to 0 (-100.00 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Sell | S | 42.00 | 10,500 | 441,000 | 866 | 11.4 K to 866 (-92.38 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 3,000 | 16,770 | 18,500 | |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 41.71 | 3,000 | 125,120 | 14,600 | 17.6 K to 14.6 K (-17.05 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 3,000 | 16,770 | 17,600 | 14.6 K to 17.6 K (+20.55 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 10,000 | 3,130 | 46,540 | |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 42.00 | 10,000 | 420,000 | 110,510 | 120.5 K to 110.5 K (-8.30 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 10,000 | 3,130 | 120,510 | 110.5 K to 120.5 K (+9.05 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 2,000 | 14,375 | 16,184 | |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 42.00 | 2,000 | 84,000 | 9,186 | 11.2 K to 9.2 K (-17.88 %) |
| Feb 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 2,000 | 14,375 | 11,186 | 9.2 K to 11.2 K (+21.77 %) |
| Jan 31 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 42.33 | 2,500 | 105,829 | 74,469 | 77 K to 74.5 K (-3.25 %) |
| Jan 31 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.69 | 3,846 | 168,031 | 1,840,828 | 1.8 M to 1.8 M (-0.21 %) |
| Jan 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 42.60 | 10,000 | 426,000 | 1,024,580 | 1 M to 1 M (-0.97 %) |
| Jan 27 2006 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 45.08 | 8,000 | 360,603 | 39,000 | 47 K to 39 K (-17.02 %) |
| Jan 27 2006 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 45.08 | 500 | 22,538 | 7,500 | 8 K to 7.5 K (-6.25 %) |
| Jan 27 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 18,184 | |
| Jan 27 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.00 | 1,000 | 45,000 | 9,186 | 10.2 K to 9.2 K (-9.82 %) |
| Jan 27 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,000 | 7,188 | 10,186 | 9.2 K to 10.2 K (+10.89 %) |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 2,000 | 11,460 | 1,791 | |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 43.00 | 2,000 | 86,000 | 26,498 | 28.5 K to 26.5 K (-7.02 %) |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 2,000 | 11,460 | 28,498 | 26.5 K to 28.5 K (+7.55 %) |
| Jan 23 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 44.34 | 2,500 | 110,846 | 76,969 | 79.5 K to 77 K (-3.15 %) |
| Jan 20 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 1,200 | 0 | 1,034,580 | 1 M to 1 M (-0.12 %) |
| Jan 20 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,300 | 0 | 1,035,780 | 1 M to 1 M (-0.22 %) |
| Jan 20 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,300 | 0 | 1,038,080 | 1 M to 1 M (-0.22 %) |
| Jan 20 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,300 | 0 | 1,040,380 | 1 M to 1 M (-0.22 %) |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.06 | 3,846 | 165,607 | 1,844,674 | 1.8 M to 1.8 M (-0.21 %) |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 21,500 | |
| Jan 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 14,600 | 12.6 K to 14.6 K (+15.87 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 12.38 | 50,000 | 618,750 | 0 | |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 12.25 | 10,000 | 122,500 | 0 | |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Payment of Exercise | F | 43.10 | 13,121 | 565,515 | 1,042,680 | 1.1 M to 1 M (-1.24 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Payment of Exercise | F | 43.10 | 14,356 | 618,744 | 1,055,801 | 1.1 M to 1.1 M (-1.34 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 12.38 | 50,000 | 618,750 | 1,070,157 | 1 M to 1.1 M (+4.90 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Payment of Exercise | F | 43.10 | 2,609 | 112,448 | 1,020,157 | 1 M to 1 M (-0.26 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Payment of Exercise | F | 43.10 | 2,842 | 122,490 | 1,022,766 | 1 M to 1 M (-0.28 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 12.25 | 10,000 | 122,500 | 1,025,608 | 1 M to 1 M (+0.98 %) |
| Jan 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 43.00 | 2,000 | 86,000 | 27,268 | 29.3 K to 27.3 K (-6.83 %) |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 40.24 | 2,500 | 100,604 | 79,469 | 82 K to 79.5 K (-3.05 %) |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Option Exercise | M | 12.25 | 10,000 | 122,500 | 0 | |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Buy | M | 12.25 | 10,000 | 122,500 | 129,706 | 119.7 K to 129.7 K (+8.35 %) |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 40.21 | 10,000 | 402,100 | 1,015,608 | 1 M to 1 M (-0.98 %) |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | M | 4.94 | 3,449 | 17,031 | 0 | |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | M | 4.94 | 9,523 | 47,025 | 0 | |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 4.94 | 3,449 | 17,031 | 29,268 | 25.8 K to 29.3 K (+13.36 %) |
| Jan 09 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 4.94 | 9,523 | 47,025 | 25,819 | 16.3 K to 25.8 K (+58.44 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 24,500 | |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 1,000 | 5,590 | 26,500 | |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,500 | 13,975 | 27,500 | |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 40.00 | 2,000 | 80,000 | 12,600 | 14.6 K to 12.6 K (-13.70 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 14,600 | 12.6 K to 14.6 K (+15.87 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 40.00 | 1,000 | 40,000 | 12,600 | 13.6 K to 12.6 K (-7.35 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 1,000 | 5,590 | 13,600 | 12.6 K to 13.6 K (+7.94 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 39.50 | 2,500 | 98,750 | 12,600 | 15.1 K to 12.6 K (-16.56 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,500 | 13,975 | 15,100 | 12.6 K to 15.1 K (+19.84 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 12.38 | 8,583 | 106,215 | 0 | |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 40.01 | 8,583 | 343,409 | 110,510 | 119.1 K to 110.5 K (-7.21 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 12.38 | 8,583 | 106,215 | 119,093 | 110.5 K to 119.1 K (+7.77 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 39.75 | 3,846 | 152,886 | 1,848,520 | 1.9 M to 1.8 M (-0.21 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 2,000 | 14,375 | 19,184 | |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 40.00 | 2,000 | 80,000 | 9,186 | 11.2 K to 9.2 K (-17.88 %) |
| Jan 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 2,000 | 14,375 | 11,186 | 9.2 K to 11.2 K (+21.77 %) |
| Dec 21 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | J | 40.34 | 5,280 | 212,995 | 123,839 | 118.6 K to 123.8 K (+4.45 %) |
| Dec 21 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 3,000 | 939 | 56,540 | |
| Dec 21 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 40.00 | 3,000 | 120,000 | 110,510 | 113.5 K to 110.5 K (-2.64 %) |
| Dec 21 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 3,000 | 939 | 113,510 | 110.5 K to 113.5 K (+2.71 %) |
| Dec 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Option Exercise | M | 2.50 | 4,754 | 11,885 | 0 | |
| Dec 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Buy | M | 2.50 | 4,754 | 11,885 | 77,323 | 72.6 K to 77.3 K (+6.55 %) |
| Dec 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 40.00 | 8,000 | 320,000 | 47,000 | 55 K to 47 K (-14.55 %) |
| Dec 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 39.03 | 3,846 | 150,112 | 1,852,366 | 1.9 M to 1.9 M (-0.21 %) |
| Dec 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Sell | S | 38.68 | 8,748 | 338,373 | 72,569 | 81.3 K to 72.6 K (-10.76 %) |
| Dec 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,333 | 19,098 | 3,791 | |
| Dec 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 38.75 | 3,333 | 129,154 | 26,498 | 29.8 K to 26.5 K (-11.17 %) |
| Dec 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,333 | 19,098 | 29,831 | 26.5 K to 29.8 K (+12.58 %) |
| Dec 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 37.20 | 2,000 | 74,401 | 32,899 | 34.9 K to 32.9 K (-5.73 %) |
| Dec 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 37.63 | 3,846 | 144,734 | 1,856,212 | 1.9 M to 1.9 M (-0.21 %) |
| Dec 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 37.72 | 10,000 | 377,165 | 1,025,608 | 1 M to 1 M (-0.97 %) |
| Dec 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,500 | 13,975 | 30,000 | |
| Dec 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 37.60 | 2,500 | 94,000 | 12,600 | 15.1 K to 12.6 K (-16.56 %) |
| Dec 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,500 | 13,975 | 15,100 | 12.6 K to 15.1 K (+19.84 %) |
| Dec 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 11,400 | 0 | 1,035,608 | 1 M to 1 M (-1.09 %) |
| Dec 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 1,400 | 0 | 1,047,008 | 1 M to 1 M (-0.13 %) |
| Dec 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,700 | 0 | 1,048,408 | 1.1 M to 1 M (-0.26 %) |
| Dec 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,700 | 0 | 1,051,108 | 1.1 M to 1.1 M (-0.26 %) |
| Dec 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,900 | 0 | 1,053,808 | 1.1 M to 1.1 M (-0.27 %) |
| Dec 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 7,000 | 2,191 | 59,540 | |
| Dec 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 37.21 | 7,000 | 260,470 | 110,510 | 117.5 K to 110.5 K (-5.96 %) |
| Dec 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 7,000 | 2,191 | 117,510 | 110.5 K to 117.5 K (+6.33 %) |
| Nov 23 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | J | 38.61 | 256 | 9,884 | 118,559 | 118.3 K to 118.6 K (+0.22 %) |
| Nov 23 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 38.40 | 10,000 | 383,963 | 1,056,708 | 1.1 M to 1.1 M (-0.94 %) |
| Nov 22 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 37.32 | 3,846 | 143,527 | 1,860,058 | 1.9 M to 1.9 M (-0.21 %) |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,333 | 19,098 | 7,124 | |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 34.35 | 3,333 | 114,489 | 26,498 | 29.8 K to 26.5 K (-11.17 %) |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,333 | 19,098 | 29,831 | 26.5 K to 29.8 K (+12.58 %) |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Option Exercise | M | 2.50 | 20,000 | 50,000 | 4,754 | |
| Nov 15 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Buy | M | 2.50 | 20,000 | 50,000 | 81,317 | 61.3 K to 81.3 K (+32.62 %) |
| Nov 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 34.75 | 2,000 | 69,500 | 34,899 | 36.9 K to 34.9 K (-5.42 %) |
| Nov 08 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Option Exercise | M | 22.60 | 8,748 | 197,705 | 51,828 | |
| Nov 08 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Sell | S | 33.95 | 8,748 | 296,975 | 61,317 | 70.1 K to 61.3 K (-12.49 %) |
| Nov 08 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Buy | M | 22.60 | 8,748 | 197,705 | 70,065 | 61.3 K to 70.1 K (+14.27 %) |
| Nov 08 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Corporate Ass ... | Sell | S | 35.09 | 11,252 | 394,833 | 61,317 | 72.6 K to 61.3 K (-15.51 %) |
| Nov 08 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 34.73 | 3,846 | 133,583 | 1,863,904 | 1.9 M to 1.9 M (-0.21 %) |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,500 | 13,975 | 32,500 | |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 33.10 | 2,500 | 82,750 | 12,600 | 15.1 K to 12.6 K (-16.56 %) |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,500 | 13,975 | 15,100 | 12.6 K to 15.1 K (+19.84 %) |
| Oct 28 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 33.83 | 12,500 | 422,848 | 1,066,708 | 1.1 M to 1.1 M (-1.16 %) |
| Nov 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 2,000 | 626 | 66,540 | |
| Nov 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 34.90 | 2,000 | 69,800 | 110,510 | 112.5 K to 110.5 K (-1.78 %) |
| Nov 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 2,000 | 626 | 112,510 | 110.5 K to 112.5 K (+1.81 %) |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 6.88 | 2,772 | 19,058 | 0 | |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 5,000 | 1,565 | 68,540 | |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 33.27 | 5,000 | 166,350 | 110,510 | 115.5 K to 110.5 K (-4.33 %) |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 5,000 | 1,565 | 115,510 | 110.5 K to 115.5 K (+4.52 %) |
| Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 33.32 | 2,772 | 92,371 | 110,510 | 113.3 K to 110.5 K (-2.45 %) |